Linagliptin

Sinónimos

• Linagliptin, BI-1356, Tradjenta, Trajenta, Ondero, Glyxambi (combination)

Linagliptin is the DPP-4 inhibitor that doesn’t need a dose adjustment for kidney or liver function – and that’s a big deal for type 2 diabetes patients who often have comorbidities. Unlike many of its peers, it’s cleared primarily via bile and gut, so it’s a safer bet for long-term use in renally impaired patients. For formulators, that means a competitive edge in a crowded market: you can offer a once-daily, 5 mg tablet that works reliably without the monitoring headaches.

We supply linagliptin as a high-purity, crystalline API that meets or exceeds pharmacopoeial standards. Every batch is rigorously tested and shipped with a full COA, so you can move from development to production with confidence.

Documentación y suministros

• Documentación: Certificado de análisis (COA), Ficha de datos de seguridad (MSDS), Ficha técnica del producto (TDS)
• Plazo de entrega: Ready to ship within 5-7 days for most orders; bulk quantities may require 2-3 weeks.
• Embalaje: Available in 1 kg, 5 kg, or 25 kg fiber drums, with custom packing options on request. We handle global logistics, ensuring safe and timely delivery.

Solicitud de presupuesto

• Nuestra dirección: Calle Main, 280, Xi'an, Shaanxi, China
• LyvBio S.L. — Correo electrónico: info@lyvbio.com